Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme

Abstract

Progressive cerebral accumulation of amyloid β-protein (Aβ) is an early and invariant feature of Alzheimer's disease. Little is known about how Aβ, after being secreted, is degraded and cleared from the extracellular space of the brain. Defective Aβ degradation could be a risk factor for the development of Alzheimer's disease in some subjects. We reported previously that microglial cells release substantial amounts of an Aβ-degrading protease that, after purification, is indistinguishable from insulin- degrading enzyme (IDE). Here we searched for and characterized a role for DE in Aβ degradation by neurons, the principal cell type that produces Aβ. Whole cultures of differentiated pheochromocytoma (PC12) cells and primary rat cortical neurons actively degraded endogenously secreted Aβ via IDE. However, unlike that in microglia, IDE in differentiated neurons was not released but localized to the cell surface, as demonstrated by biotinylation. Undifferentiated PC12 cells released IDE into their medium, whereas after differentiation, IDE was cell associated but still degraded Aβ in the medium. Overexpression of IDE in mammalian cells markedly reduced the steady- state levels of extracellular Aβ40 and Aβ42, and the catalytic site mutation (E111Q) abolished this effect. We observed a novel membrane- associated form of IDE that is ~5 kDa larger than the known cytosolic form in a variety of cells, including differentiated PC12 cells. Our results support a principal role for membrane-associated and secreted IDE isoforms in the degradation and clearance of naturally secreted Aβ by neurons and microglia.